Takeda taps Biological E to ramp up Qdenga manufacturing capacity on quest to make 100M doses a year zbecker Tue, 02/27/2024 – 11:13 More: Takeda taps Biological E to ramp up Qdenga manufacturing capacity on quest to make 100M doses
read morePerrigo plots hundreds of job cuts as it embarks on restructuring initiative fkansteiner Tue, 02/27/2024 – 11:01 More: Perrigo plots hundreds of job cuts as it embarks on restructuring initiative Source: fierce
read moreOne Up, One Down: Allecra scores FDA nod for antibiotic combo after Venatorx hit with rejection kdunleavy Tue, 02/27/2024 – 10:59 More: One Up, One Down: Allecra scores FDA nod for antibiotic combo after Venatorx hit with rejection Source: fierce
read moreAstraZeneca finally drops roxadustat US rights after FDA rejection, trial failure aliu Tue, 02/27/2024 – 10:15 More: AstraZeneca finally drops roxadustat US rights after FDA rejection, trial failure Source: fierce
read moreOrganon’s prolific asthma med Singulair needs new safety labeling, NY attorney general argues fkansteiner Tue, 02/27/2024 – 08:58 More: Organon's prolific asthma med Singulair needs new safety labeling, NY attorney general argues Source: fierce
read moreThe white paper outlines three strategic recommendations to support further research More: UK and Netherlands researchers call for funding to investigate cancer treatments Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals